ArticlePeerJ2021
Denouncing the use of field-specific effect size distributions to inform magnitude.
Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A tutorial for calculating field-specific effect size distributions.Behavior research methods · 2026Article
- Unmasking hidden pathways: how household air pollution and lifestyle are associated with quality of life in Yunnan outpatients.Frontiers in public health · 2026Article
- Ready to ROC? A tutorial on simulation-based power analyses for null hypothesis significance, minimum-effect, and equivalence testing for ROC curve analyses.Behavior research methods · 2025Article
- Vocal and Facial Behavior During Affect Production in Autism Spectrum Disorder.Journal of speech, language, and hearing research : JSLHR · 2025Article
- Cerebrospinal Creatine Kinase BB Isoenzyme: A Biomarker for Predicting Outcome After Cardiac Arrest.Neurocritical care · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An effect size (ES) provides valuable information regarding the magnitude of effects, with the interpretation of magnitude being the most important. Interpreting ES magnitude requires combining information from the numerical ES value and the context of the research. However, many researchers adopt popular benchmarks such as those proposed by Cohen. More recently, researchers have proposed interpreting ES magnitude relative to the distribution of observed ESs in a specific field, creating unique benchmarks for declaring effects small, medium or large. However, there is no valid rationale whatsoever for this approach. This study was carried out in two parts: (1) We identified articles that proposed the use of field-specific ES distributions to interpret magnitude (primary articles); and (2) We identified articles that cited the primary articles and classified them by year and publication type. The first type consisted of methodological papers. The second type included articles that interpreted ES magnitude using the approach proposed in the primary articles. There has been a steady increase in the number of methodological and substantial articles discussing or adopting the approach of interpreting ES magnitude by considering the distribution of observed ES in that field, even though the approach is devoid of a theoretical framework. It is hoped that this research will restrict the practice of interpreting ES magnitude relative to the distribution of ES values in a field and instead encourage researchers to interpret such by considering the specific context of the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.